High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance.

Name: High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance.
Author: García-Marco, José A

High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance. — المؤلف: García-Marco, José A — Haematologica 20200713

المؤلف: García-Marco, José A
النشر: Haematologica 20200713
الوصف: 2249-2257 p.
الموضوعات: Adult؛ Aged؛ Antineoplastic Combined Chemotherapy Protocols؛ Cyclophosphamide؛ Female؛ Humans؛ Leukemia, Lymphocytic, Chronic, B-Cell؛ Maintenance Chemotherapy